Neuronetics, Inc. — Director's Dealing 2018

Jun 28, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2018-06-27

Reporting Person: Harper Gregory (VP of R&D, Ops. and Prod. Dev.)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$3.19	2026-10-11	Common Stock (76536)		Direct
Employee Stock Option (Right to Buy)	$2.32	2027-07-19	Common Stock (12085)		Direct
Employee Stock Option (Right to Buy)	$4.06	2027-12-06	Common Stock (25203)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on September 12, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F2: Twenty-five percent (25%) of the shares subject to the option shall vest on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F3: Twenty-five percent (25%) of the shares subject to the option shall vest on December 7, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.